Effect of Non-alcoholic Beer in Cirrhosis
- Conditions
- Endothelial DysfunctionNutritional StatusQuality of Life
- Interventions
- Other: controlDietary Supplement: Non-alcoholic beer
- Registration Number
- NCT04041115
- Lead Sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Brief Summary
The implementation of nutritional strategies targeting several variables at once could benefit patients with cirrhosis. Non-alcoholic beer has different compounds derived from hops that exert antioxidant, anti-inflammatory and nutritional properties. The aim of this study is to evaluate the effect of diet + exercise and non-alcoholic beer on nutritional status, endothelial function and quality of life in patients with cirrhosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
- Liver Cirrhosis of any aetiology (liver biopsy or a combination of clinical and biochemical variables plus evidence of portal hypertension); without decompensation during the past month; serum creatinine <1.5 mg%; able to attend the appointed visits and willing to participate in the study.
- Severe concomitant cardiopulmonary diseases; decompensated type 2 Diabetes Mellitus, insulin use or proliferative diabetic retinopathy; orthopedic or osteomuscular limitations; any type of cancer; primary sclerosing cholangitis and inflammatory bowel disease.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control control personalized nutritional therapy + aerobic exercise Non-alcoholic Beer Non-alcoholic beer non-alcoholic beer + personalized nutritional therapy + aerobic exercise
- Primary Outcome Measures
Name Time Method Quality of life questionnaire 8 weeks Improvement in quality of life questionnaire CLDQ (chronic liver disease questionnaire)
Nutritional status 8 weeks improvement in impedance-derived phase angle (PhA)
Endothelial dysfunction 8 weeks improvement in serum markers of endothelial function (v.gr. nitric oxide, NO; prostacyclin, PGI2, etc.)
Changes in the heterogeneity of gut Microbiota 8 weeks Changes in the heterogeneity of fecal microbiota in terms of bacterial diversity will be assessed
Endothelial function 8 weeks improvement in flow-mediated dilation (brachial artery)
- Secondary Outcome Measures
Name Time Method